Multi-symptom asthma as an indication of disease severity in epidemiology

European Respiratory Journal

Volumn 38, Issue 4, 2011, Pages 825-832

  Ekerljung, L ^a   Bossios, A ^a   Lotvall J ^a   Olin, A C ^a   Ronmark E ^c   Wennergren, G ^b   Toren K ^a   Lundback B ^a,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SUNDERBY HOSPITAL   (Sweden)

Author keywords

Epidemiology; Multi symptom asthma; Population study; Risk factors

Indexed keywords

NITRIC OXIDE;

ADOLESCENT; ADULT; AGED; ALLERGY; ARTICLE; ASTHMA; BODY MASS; CLINICAL EXAMINATION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; DUST; DYSPNEA; EPIDEMIOLOGICAL DATA; FAMILY HISTORY; FEMALE; FORCED EXPIRATORY VOLUME; FUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTI SYMPTOM ASTHMA; OCCUPATIONAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT DISEASE; RISK FACTOR; WHEEZING;

ADOLESCENT; ADULT; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; DYSPNEA; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTAL SERVICE; PREVALENCE; QUESTIONNAIRES; RESPIRATORY SOUNDS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SWEDEN; YOUNG ADULT;

EID: 80053483537     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00143710     Document Type: Article

References (34)

1. Rabe KF, Adachi M, Lai CK, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004; 114: 40-47. (Pubitemid 39022491)
2. The EMFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 2003; 22: 470-477.
3. Jatakanon A, Uasuf C, Maziak W, et al. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160: 1532-1539.
4. Le Moual N, Siroux V, Pin I, et al. Asthma severity and exposure to occupational asthmogens. Am J Respir Crit Care Med 2005; 172: 440-445. (Pubitemid 41117389)
5. Juniper EF, Wisniewski ME, Cox FM, et al. Relationship between quality of life and clinical status in asthma: a factor analysis. Eur Respir J 2004; 23: 287-291. (Pubitemid 38195516)
6. Tough SC, Hessel PA, Ruff M, et al. Features that distinguish those who die from asthma from community controls with asthma. J Asthma 1998; 35: 657-665. (Pubitemid 29015373)
7. Godard P, Chanez P, Siraudin L, et al. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir J 2001; 19: 61-67. (Pubitemid 34105569)
8. Jansson SA, Rönmark E, Forsberg B, et al. The economic consequences of asthma among adults in Sweden. Respir Med 2007; 101: 2263-2270. (Pubitemid 47471410)
9. De Marco R, Marcon A, Jarvis D, et al. Prognostic factors of asthma severity: a 9-year international prospective cohort study. J Allergy Clin Immunol 2006; 117: 1249-1256. (Pubitemid 43795727)
10. Lötvall J, Ekerljung L, Rönmark EP, et al. West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma. Respir Res 2009; 10: 94.
11. Rönmark EP, Ekerljung L, Lö tvall J, et al. Large scale questionnaire survey on respiratory health in Sweden: effects of late- and nonresponse. Respir Med 2009; 103: 1807-1815.
12. Wennergren G, Ekerljung L, Alm B, et al. Asthma in late adolescence - farm childhood is protective and the prevalence increase has levelled off. Pediatr Allergy Immunol 2010; 21: 806-813.
13. Heinrich J, Hoelscher B, Frye C, et al. Trends in prevalence of atopic diseases and allergic sensitization in children in Eastern Germany. Eur Respir J 2002; 19: 1040-1046. (Pubitemid 34649616)
14. Lundbäck B, Nyström L, Rosenhall L, et al. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J 1991; 4: 257-266.
15. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. Gaithersburg, GINA, 2009.
16. Torén K, Blanc PD. Asthma caused by occupational exposures is common - a systematic analysis of estimates of the populationattributable fraction. BMC Pulm Med 2009; 9: 7.
17. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. www.ginasthma.org/pdf/GINA-Report-2010.pdf Date last accessed: August 17, 2010. Date last updated: 2010.
18. Ponte EV, Franco R, Nascimento HF, et al. Lack of control of severe asthma is associated with co-existence of moderate-to-severe rhinitis. Allergy 2008; 63: 564-569. (Pubitemid 351490397)
19. Rabe KF, Vermeire PA, Soriano JB, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000; 16: 802-807. (Pubitemid 32049363)
20. Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178: 218-224.
21. Chung KF, Godard P, Adelroth E, et al. Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. Eur Respir J 1999; 13: 1198-1208. (Pubitemid 29288952)
22. Janson C, Chinn S, Jarvis D, et al. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J 1997; 10: 1795-1802. (Pubitemid 27368372)
23. Heaney LG, Conway E, Kelly C, et al. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax 2003; 58: 561-566. (Pubitemid 36808124)
24. Robinson DS, Campbell DA, Durham SR, et al. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003; 22: 478-483. (Pubitemid 37098929)
25. Chen H, Gould MK, Blanc PD, et al. Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol 2007; 120: 396-402. (Pubitemid 47103330)
26. Juniper EF. Effect of asthma on quality of life. Can Respir J 1998; 5: Suppl. A, 77A-84A.
27. Gaga M, Papageorgiou N, Yiourgioti G, et al. Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire. Clin Exp Allergy 2005; 35: 954-959. (Pubitemid 41032546)
28. Lundbäck B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998; 28: Suppl. 2, 3-10.
29. Braun-Fahrländer C, Gassner M, Grize L, et al. No further increase in asthma, hay fever and atopic sensitisation in adolescents living in Switzerland. Eur Respir J 2004; 23: 407-413. (Pubitemid 38344377)
30. Price D, Zhang Q, Kocevar VS, et al. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy 2005; 35: 282-287. (Pubitemid 40516652)
31. Braman SS, Barrows AA, DeCotiis BA, et al. Airway hyperresponsiveness in allergic rhinitis. A risk factor for asthma. Chest 1987; 91: 671-674. (Pubitemid 17069162)
32. Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999; 104: 301-304. (Pubitemid 29420424)
33. Kanani AS, Broder I, Greene JM, et al. Correlation between nasal symptoms and asthma severity in patients with atopic and nonatopic asthma. Ann Allergy Asthma Immunol 2005; 94: 341-347. (Pubitemid 40396579)
34. Rönmark E, Andersson C, Nyström L, et al. Obesity increases the risk of incident asthma among adults. Eur Respir J 2005; 25: 282-288. (Pubitemid 40246528)